AP2002002401A0 - Histamine receptor antagonists. - Google Patents

Histamine receptor antagonists.

Info

Publication number
AP2002002401A0
AP2002002401A0 APAP/P/2002/002401A AP2002002401A AP2002002401A0 AP 2002002401 A0 AP2002002401 A0 AP 2002002401A0 AP 2002002401 A AP2002002401 A AP 2002002401A AP 2002002401 A0 AP2002002401 A0 AP 2002002401A0
Authority
AP
ARIPO
Prior art keywords
histamine
receptor antagonists
histamine receptor
receptor
antagonist
Prior art date
Application number
APAP/P/2002/002401A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP2002002401A0 publication Critical patent/AP2002002401A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/2002/002401A 2001-01-17 2002-01-17 Histamine receptor antagonists. AP2002002401A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
AP2002002401A0 true AP2002002401A0 (en) 2002-03-31

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002401A AP2002002401A0 (en) 2001-01-17 2002-01-17 Histamine receptor antagonists.

Country Status (31)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223D0 (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
MXPA05002577A (es) * 2002-09-06 2005-09-20 Johnson & Johnson Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma.
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére

Also Published As

Publication number Publication date
NO20033223L (no) 2003-07-16
CN1486178A (zh) 2004-03-31
BR0206502A (pt) 2003-10-21
SV2003000849A (es) 2003-01-13
HUP0302767A2 (hu) 2003-11-28
CR6983A (es) 2003-11-25
GT200200003A (es) 2002-08-19
AR032101A1 (es) 2003-10-22
SK8572003A3 (en) 2004-07-07
MA26980A1 (fr) 2004-12-20
ZA200304180B (en) 2004-06-15
MXPA03006408A (es) 2003-10-15
PL362793A1 (en) 2004-11-02
OA12440A (en) 2006-05-22
EP1353657A1 (en) 2003-10-22
TNSN02003A1 (fr) 2005-12-23
WO2002056871A2 (en) 2002-07-25
IL156087A0 (en) 2003-12-23
NO20033223D0 (no) 2003-07-16
EA200300537A1 (ru) 2004-02-26
KR20030069216A (ko) 2003-08-25
IS6818A (is) 2003-05-15
BG107834A (bg) 2004-01-30
ECSP034692A (es) 2003-08-29
CA2435121A1 (en) 2002-07-25
PA8537101A1 (es) 2002-08-29
CZ20031853A3 (cs) 2004-07-14
EE200300335A (et) 2003-12-15
DOP2002000325A (es) 2003-01-31
GB0101223D0 (en) 2001-02-28
JP2004517883A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
GB0115862D0 (en) Compounds
AU3652102A (en) Compounds and their uses
HK1099292A1 (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
ATE372768T1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor- antagoniste
AU2002350961A1 (en) Ethylene diamine derivatives and their use as orexin-receptor antagonists
IL161074A0 (en) Lactam derivatives as antagonists for human 11cby receptors
IL155236A0 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA03010158A (es) Sulfonamidas.
TWI256304B (en) Pharmaceutical compositions based on azetidine derivatives
AP2002002401A0 (en) Histamine receptor antagonists.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA05006587A (es) Compuestos de tiazol como derivados de antagonistas del receptor de la integrina.
WO2002089740A3 (en) Sulfonamides
MXPA05012279A (es) Derivados de bencil sulfonamida.
WO2004024683A3 (en) COMPOSITIONS FOR INDUCING INCREASED LEVELS OF β-CHEMOKINES AND METHODS OF USE THEREFOR
UY27124A1 (es) Antagonistas de receptores de histamina
BR0113202A (pt) Compostos de trioxepano